Table 4A.
Patient characteristics.
| Patients characteristics | At 2 year | P-value | |
|---|---|---|---|
| Euthyroidism (n = 41) | Hypothyroidism (n = 20) | ||
| Sex (female, %) | 73.2% | 80% | 0.791 |
| Treatment method (PSL, %) | 29.3% | 5% | 0.066 |
| Age (year) | 43.7 ± 9.1 | 44.8 ± 9.7 | 0.695 |
| 43.78 | |||
| Initial levels of FT3 (pmol/L) | 7.6 ± 2.9 | 7.3 (5.8–10.1) | 0.419 |
| Initial levels of FT4 (pmol/L) | 22.6 ± 8.0 | 23.4 (16.0–30.5) | 0.510 |
| Initial levels of TSH (mIU/L) | 0.014 (0.004–0.170) | 0.020 (0.005–0.604) | 0.424 |
| Initial levels of TPOAb (IU/mL) | 1.2 (0.5–9.3) | 0.6 (0.5–8.4) | 0.901 |
| Initial levels of TgAb (IU/mL) | 7.8 (2.4–22.2) | 5.4 (2.6–23.5) | 0.752 |
| Maximal FT3b (pmol/L) | 7.7 (6.0–10.5) | 9.3 ± 4.1 | 0.500 |
| Maximal FT4b (pmol/L) | 25.3 ± 8.7 | 27.6(21.0–33.2) | 0.293 |
| Minimal TSHb (mIU/L) | 0.009 (0.003–0.043) | 0.005 (0.004–0.173) | 0.933 |
| Maximal TSHb (mIU/L) | 4.5 (2.6–7.7) | 17.1 (8.3–70.5) | 0.000 |
| Maximal ESRb (mmH2O) | 54.5 (44.0–77.3) | 58.0 ± 32.2 | 0.661 |
| ESR recovery time (day) | 57.4 ± 39.5 | 59.1 ± 48.1 | 0.893 |